Ameriprise’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$102M Sell
588,069
-91,874
-14% -$15.9M 0.03% 546
2025
Q1
$106M Sell
679,943
-22,618
-3% -$3.53M 0.03% 517
2024
Q4
$96.7M Buy
702,561
+32,844
+5% +$4.52M 0.02% 560
2024
Q3
$100M Buy
669,717
+9,055
+1% +$1.35M 0.03% 547
2024
Q2
$90.1M Buy
660,662
+605,496
+1,098% +$82.6M 0.02% 559
2024
Q1
$8.34M Sell
55,166
-7,144
-11% -$1.08M ﹤0.01% 1952
2023
Q4
$7.85M Buy
62,310
+1,734
+3% +$218K ﹤0.01% 1993
2023
Q3
$5.67M Sell
60,576
-8,043
-12% -$753K ﹤0.01% 2183
2023
Q2
$6.12M Buy
68,619
+14,586
+27% +$1.3M ﹤0.01% 2183
2023
Q1
$5.79M Sell
54,033
-103
-0.2% -$11K ﹤0.01% 2213
2022
Q4
$6.61M Sell
54,136
-331
-0.6% -$40.4K ﹤0.01% 2088
2022
Q3
$5.63M Buy
54,467
+4,302
+9% +$444K ﹤0.01% 2125
2022
Q2
$4.66M Sell
50,165
-1,644
-3% -$153K ﹤0.01% 2332
2022
Q1
$6.08M Buy
51,809
+3,232
+7% +$379K ﹤0.01% 2293
2021
Q4
$6.54M Sell
48,577
-2,610
-5% -$351K ﹤0.01% 2280
2021
Q3
$8.16M Sell
51,187
-1,344
-3% -$214K ﹤0.01% 2026
2021
Q2
$6.91M Buy
52,531
+4,494
+9% +$591K ﹤0.01% 2220
2021
Q1
$6.19M Sell
48,037
-22,119
-32% -$2.85M ﹤0.01% 2258
2020
Q4
$11.7M Sell
70,156
-2,674
-4% -$446K ﹤0.01% 1630
2020
Q3
$11.2M Sell
72,830
-933
-1% -$144K ﹤0.01% 1476
2020
Q2
$10.9M Buy
73,763
+61
+0.1% +$9.02K ﹤0.01% 1477
2020
Q1
$8.3M Sell
73,702
-24,731
-25% -$2.78M ﹤0.01% 1531
2019
Q4
$13.7M Buy
98,433
+240
+0.2% +$33.4K 0.01% 1488
2019
Q3
$9.46M Sell
98,193
-7,838
-7% -$755K ﹤0.01% 1737
2019
Q2
$12.2M Buy
106,031
+42,448
+67% +$4.89M 0.01% 1570
2019
Q1
$7.48M Buy
+63,583
New +$7.48M ﹤0.01% 1935